FLUTICASONE PROPIONATE | A076504 | HIKMA PHARMACEUTICALS USA INC
| Petition | Type | Filed | Status | Petitioner |
|---|---|---|---|---|
Citizen Petition from Lachman Consultant Services, Inc. FDA-2016-P-1725 · 5 docket documents Lachman Consultant Services, Inc. filed this petition on behalf of a client requesting that the FDA determine whether GSK's Flonase (fluticasone propionate) Nasal Spray, 0.05 mg (Rx), approved under NDA 020121, has been voluntarily withdrawn for safety or effectiveness reasons, and if not, to design | 505(q) | 2016-06-23 | Granted | Lachman Consultant Services, Inc. |
Source: Regulations.gov. FDA citizen petitions matched by application number.
Highest NADAC/Unit
$0.4421
per gm
Lowest NADAC/Unit
$0.4421
per gm
Brand NDCs
0
Generic NDCs
1
| NDC Description | NADAC/Unit | Unit | Type | Generic NADAC | Effective |
|---|---|---|---|---|---|
| 00054327099FLUTICASONE PROP 50 MCG SPRAY | $0.4421 | GM | Generic | — | 2026-06-17 |
Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.
No patent or exclusivity listings for this strength.